Pfizer COVID-19 Vaccine May Be Less Effective In Obese People

Click image to zoom

Pfizer COVID-19 Vaccine May Be Less Effective In Obese People

The Pfizer logo is seen refelcted in a drop on a needle in this illustration photo in Warsaw, Poland on January 16, 2021. Pfizer’s vaccine may be less effective in protecting obese people from coronavirus accorindg to scientists. Researchers in Rome, Italy discovered that obese people who received two doses of the Pfizer vaccine generated a weaker antibody response. The study has been distributed on the Medrxiv pre-print server. (Photo by Jaap Arriens/NurPhoto)


Photo Details


Usage Guidelines

Editorial Use Only. Commercial use is not permitted without prior authorization.
Contact us for licensing inquiries

Related Keywords

Rights-Managed (RM) · Single Editorial Use

License This Image

Configure usage rights. Price adjusts in real time.

One license covers one publication within the parameters you select. Each additional publication (e.g. separate articles, posts, issues) requires its own license. License terms ›

Media Type
Image Size
License Duration
Territory
Page Placement
Monthly Page Views
Print Run / Circulation
Need custom or commercial rights? Contact Sales · [email protected]
2026 NurPhoto. All rights reserved. This image is the property of NurPhoto and is protected under international copyright laws.